| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72205-075-30 | 72205-075 | HUMAN PRESCRIPTION DRUG | Deferasorox | Deferasirox | GRANULE | ORAL | 20210318 | N/A | ANDA | ANDA214650 | Novadoz Pharmaceuticals LLC | DEFERASIROX | 180 mg/1 | 30 PACKET in 1 CARTON (72205-075-30) / 1 GRANULE in 1 PACKET (72205-075-61) |
| 72205-176-30 | 72205-176 | HUMAN PRESCRIPTION DRUG | Deferasorox | Deferasirox | GRANULE | ORAL | 20220521 | N/A | ANDA | ANDA214650 | Novadoz Pharmaceuticals LLC | DEFERASIROX | 90 mg/1 | 30 PACKET in 1 CARTON (72205-176-30) / 1 GRANULE in 1 PACKET (72205-176-61) |
| 72205-076-30 | 72205-076 | HUMAN PRESCRIPTION DRUG | Deferasorox | Deferasirox | GRANULE | ORAL | 20210318 | N/A | ANDA | ANDA214650 | Novadoz Pharmaceuticals LLC | DEFERASIROX | 360 mg/1 | 30 PACKET in 1 CARTON (72205-076-30) / 1 GRANULE in 1 PACKET (72205-076-61) |